Researchers at Rutgers Robert Wood Johnson Medical School have reported the first instance of COVID-19 triggering a recurrence of Guillain–Barré Syndrome – a rare disorder where the body’s immune system attacks nerves and can lead to respiratory failure and death. While there have been several reports of Guillain–Barré Syndrome following COVID-19, this is the first in which COVID-19 actually triggered a recurrence of the condition – in a 54-year-old man who had suffered with Guillain–Barré Syndrome twice and had a third occurrence after testing positive for COVID-19, according to the Rutgers case report published in the journal Pathogens. To read the full story.
Home / News / Rutgers Reports First Instance of COVID-19 Triggering Recurrent Guillain-Barré Syndrome
Recent Posts
- Majority of Americans Experience Some Form of Gun Violence in Person.
- Family Sparks NJIT Scholar’s Research into Biomedical Engineering.
- Extreme Monsoon Changes Threaten the Bay of Bengal’s Role as a Critical Food Source.
- New NJACTS Publication
- Join NJ ACTS Biostatistics, Epidemiology, Research Design (BERD) Workshop Series on June 19th
Categories
- Community (2,272)
- Covid (986)
- CTO Events (6)
- News (2,894)
- Pilots (21)